SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

September 04, 2012 08:35 ET

MMRGlobal Executives on the Move, Company to Attend APAC Innovation Showcase With Alcatel-Lucent and ng Connect

LOS ANGELES, CA--(Marketwire - Sep 4, 2012) -   MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that Richard M. Lagani, Executive Vice President, is now headquartered in London. Lagani will focus on launching MMR's signature Personal Health Record (PHR), MyMedicalRecords, to Travel Guard, a Chartis Company and the premier provider of travel insurance covering more than six million travelers worldwide. Lagani will also manage other opportunities with insurers, hospitals and healthcare professionals overseas and be part of the MMR management team for its joint venture in China entitled Unis Tonghe MMR International Management Service Company, Ltd. Additionally, CEO Bob Lorsch is headed to Europe this week for meetings with additional international licensees and international investors.

On September 25th, Rich Teich, Manager of Major Market Sales, is scheduled to be in Australia to represent the Company at an ng Connect program entitled "Building 4G Service Buzz for Your Brand." MMR along with its Australian licensee VisiInc PLC will be introduced at one-on-one meetings to at least four of the world's largest Alcatel-Lucent carriers/customers that include Optus, Telstra, Vodaphone Hutchison Australia, and NBN Co. MMR will showcase patented features of its patient-centric MyMedicalRecords PHR and MMRPro system for healthcare professionals as 4G applications including new wireless and telemedicine applications with other ng Connect partners. 

"Our relationship with ng Connect opens the door to opportunities to show some of the world's largest telecommunications carriers, government agencies and healthcare consortiums the value of offering Personal Health Records such as MyMedicalRecords to their customers, users and subscribers," said Lorsch.

Through Alcatel-Lucent's government sales team, Teich and VisiInc CEO Jacques Blandin also plan on meeting with Australian government officials to address opportunities created from the launch of Australia's Personal Health Record on July 1, 2012 as well as interoperability of numerous eHealth and telehealth platforms being used in other countries around the world.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's products and services at

Forward-Looking Statements 

Statements in this press release that are not strictly historical in nature, including future performance, expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMRGlobal, Inc.'s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk our products and services are not adopted or viewed favorably by the healthcare community and retail market, both in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; scheduling; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing, exploiting and defending our intellectual property rights including those pertaining to our biotechnology assets; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the United States Securities and Exchange Commission. MMRGlobal, Inc. is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. 

Contact Information